J&J's Q1 earnings miss was because of Covid-19 vaccine, says CFO Joseph Wolk

CNBC's Meg Tirrell sits down with Johnson & Johnson CFO Joseph Wolk to break down the company's first-quarter earnings report, which missed Wall Street's revenue estimates.